• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ga or F for Prostate Cancer Imaging?

作者信息

Kesch Claudia, Kratochwil Clemens, Mier Walter, Kopka Klaus, Giesel Frederik L

机构信息

Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; and.

出版信息

J Nucl Med. 2017 May;58(5):687-688. doi: 10.2967/jnumed.117.190157. Epub 2017 Apr 13.

DOI:10.2967/jnumed.117.190157
PMID:28408526
Abstract
摘要

相似文献

1
Ga or F for Prostate Cancer Imaging?镓还是氟用于前列腺癌成像？
J Nucl Med. 2017 May;58(5):687-688. doi: 10.2967/jnumed.117.190157. Epub 2017 Apr 13.
2
Validation of a [AlF]PSMA-11 preparation for clinical applications.用于临床应用的[AlF]PSMA - 11制剂的验证。
Appl Radiat Isot. 2017 Dec;130:102-108. doi: 10.1016/j.apradiso.2017.09.003. Epub 2017 Sep 6.
3
Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.用于前列腺癌 PET 成像的 Al18F- 和 68Ga 标记 gastrin-releasing peptide 受体拮抗剂的临床前比较。
J Nucl Med. 2014 Dec;55(12):2050-6. doi: 10.2967/jnumed.114.141143. Epub 2014 Nov 20.
4
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.18F-氟甲基胆碱与 68Ga-PSMA PET/CT 在经治愈性治疗后 PSA 升高且正在考虑靶向治疗的前列腺癌患者中的前瞻性比较。
J Nucl Med. 2015 Aug;56(8):1185-90. doi: 10.2967/jnumed.115.160382. Epub 2015 Jun 25.
5
Synthesis and pre-clinical evaluation of a new class of high-affinity F-labeled PSMA ligands for detection of prostate cancer by PET imaging.一类用于正电子发射断层扫描（PET）成像检测前列腺癌的新型高亲和力F标记前列腺特异性膜抗原（PSMA）配体的合成及临床前评估。
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):647-661. doi: 10.1007/s00259-016-3556-5. Epub 2016 Nov 15.
6
Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.镓-68前列腺特异性膜抗原正电子发射断层显像
PET Clin. 2017 Apr;12(2):219-234. doi: 10.1016/j.cpet.2016.12.004. Epub 2017 Feb 1.
7
The Role of Positron Emission Tomography With (68)Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy.正电子发射断层扫描结合（68）镓（Ga）标记的前列腺特异性膜抗原（PSMA）在根治性治疗前和根治性前列腺切除术后器官局限性和局部晚期前列腺癌患者管理中的作用
Urology. 2016 Sep;95:11-5. doi: 10.1016/j.urology.2015.12.048. Epub 2016 Jan 11.
8
PSMA ligands in prostate cancer - Probe optimization and theranostic applications.前列腺癌中的 PSMA 配体 - 探针优化与治疗应用。
Methods. 2017 Nov 1;130:42-50. doi: 10.1016/j.ymeth.2017.06.026. Epub 2017 Jun 28.
9
Imaging of Prostate Cancer Using Gallium-68-Labeled Bombesin.使用镓-68标记的蛙皮素对前列腺癌进行成像
PET Clin. 2017 Apr;12(2):159-171. doi: 10.1016/j.cpet.2016.11.003. Epub 2017 Jan 20.
10
Clinical PET Imaging in Prostate Cancer.前列腺癌的临床正电子发射断层显像
Radiographics. 2017 Sep-Oct;37(5):1512-1536. doi: 10.1148/rg.2017170035. Epub 2017 Aug 11.

引用本文的文献

1
F-NOTA-NFB PET/MRI in glioma recurrence: comparison with C-methionine PET/MRI and contrast-enhanced MRI.F-NOTA-NFB PET/MRI在胶质瘤复发中的应用：与C-蛋氨酸PET/MRI及对比增强MRI的比较
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05159-x.
2
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis.[68Ga]镓-PSMA-11与[18F]氟-PSMA-1007 PET/CT在前列腺癌根治术和淋巴结清扫术候选患者淋巴结分期诊断准确性的评估：单机构分析
Diagnostics (Basel). 2025 Jun 12;15(12):1492. doi: 10.3390/diagnostics15121492.
3
Imaging Efficacy of [F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study.
以组织病理学为金标准评估[F]CTT1057 PET检测PSMA阳性肿瘤的成像效能：GuideView 2/3期前瞻性多中心研究结果
J Nucl Med. 2025 Aug 1;66(8):1232-1238. doi: 10.2967/jnumed.124.269007.
4
Macrophage mannose receptor CD206-targeted PET imaging in experimental acute myocardial infarction.实验性急性心肌梗死中巨噬细胞甘露糖受体CD206靶向正电子发射断层显像
EJNMMI Res. 2025 Jun 4;15(1):66. doi: 10.1186/s13550-025-01254-2.
5
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinoma.一项关于腺样囊性癌患者的PSMA靶向F-18-DCFPyL PET成像的初步研究。
Sci Rep. 2025 May 16;15(1):17104. doi: 10.1038/s41598-025-01515-z.
6
Preclinical and clinical evaluation of [Cu]Cu-PSMA-Q PET/CT for prostate cancer detection and its comparison with [F]FDG imaging.用于前列腺癌检测的[铜]Cu-PSMA-Q PET/CT的临床前和临床评估及其与[氟]FDG成像的比较。
Sci Rep. 2025 Apr 25;15(1):14431. doi: 10.1038/s41598-025-98757-8.
7
Current status of FAP-directed cancer theranostics: a bibliometric analysis.家族性腺瘤性息肉病导向的癌症诊疗一体化的现状：一项文献计量学分析
Biophys Rep. 2024 Dec 31;10(6):388-402. doi: 10.52601/bpr.2024.240022.
8
Enhancing the radionuclide theranostic concept through the radiohybrid approach.通过放射杂交方法强化放射性核素诊疗概念。
RSC Med Chem. 2024 Nov 25. doi: 10.1039/d4md00591k.
9
Comparison of early and standard F-PSMA-11 PET/CT imaging in treatment-naïve patients with prostate cancer.初治前列腺癌患者早期与标准F-PSMA-11 PET/CT成像的比较
Ann Nucl Med. 2025 Mar;39(3):295-302. doi: 10.1007/s12149-024-02000-9. Epub 2024 Nov 10.
10
Aspects and prospects of preclinical theranostic radiopharmaceutical development.临床前治疗放射性药物开发的方面和前景。
Theranostics. 2024 Oct 7;14(17):6446-6470. doi: 10.7150/thno.100339. eCollection 2024.